TRIPALMITIN

TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.

Cross Reference

Introduction

To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with TRIPALMITIN?

TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with TRIPALMITIN

MeSH term MeSH ID Detail
Leishmaniasis, Visceral D007898 13 associated lipids
Respiratory Distress Syndrome, Newborn D012127 5 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
HIV-Associated Lipodystrophy Syndrome D039682 3 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with TRIPALMITIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with TRIPALMITIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with TRIPALMITIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with TRIPALMITIN?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with TRIPALMITIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with TRIPALMITIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with TRIPALMITIN

Download all related citations
Per page 10 20 50 100 | Total 272
Authors Title Published Journal PubMed Link
Kuo YC and Chung CY Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir. 2011 Colloids Surf B Biointerfaces pmid:21865017
Kato T et al. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. 2008 Diabetes pmid:18458149
Moffitt JH et al. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. 2005 Diabetologia pmid:16094531
Collins SC et al. Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon. 2008 Diabetologia pmid:18622593
Jones E et al. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. 2014 Drug Dev Ind Pharm pmid:24576267
Seetapan N et al. Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency. 2010 Drug Dev Ind Pharm pmid:20184417
Nakasato DY et al. Evaluation of the effects of polymeric chitosan/tripolyphosphate and solid lipid nanoparticles on germination of Zea mays, Brassica rapa and Pisum sativum. 2017 Ecotoxicol. Environ. Saf. pmid:28437729
Liu KM and Liu KJ Lipase-catalyzed synthesis of palmitanilide: Kinetic model and antimicrobial activity study. 2016 Enzyme Microb. Technol. pmid:26672452
Witzleb R et al. Solid lipid extrusion with small die diameters--electrostatic charging, taste masking and continuous production. 2011 Eur J Pharm Biopharm pmid:20940049
Maschke A et al. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof. 2007 Eur J Pharm Biopharm pmid:17070025
Windbergs M et al. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution. 2009 Eur J Pharm Biopharm pmid:18588976
Wasutrasawat P et al. Drug solubilisation in lipid nanoparticles containing high melting point triglycerides. 2013 Eur J Pharm Biopharm pmid:23688806
Souto EB et al. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. 2004 Eur J Pharm Biopharm pmid:15207541
Hathout RM and Metwally AA Towards better modelling of drug-loading in solid lipid nanoparticles: Molecular dynamics, docking experiments and Gaussian Processes machine learning. 2016 Eur J Pharm Biopharm pmid:27449631
Windbergs M et al. Influence of structural variations on drug release from lipid/polyethylene glycol matrices. 2009 Eur J Pharm Sci pmid:19406229
Lopes R et al. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. 2012 Eur J Pharm Sci pmid:21983568
Cavalli R et al. Preparation and characterization of solid lipid nanospheres containing paclitaxel. 2000 Eur J Pharm Sci pmid:10838020
Noiriel A et al. Expression in yeast of a novel phospholipase A1 cDNA from Arabidopsis thaliana. 2004 Eur. J. Biochem. pmid:15355352
Royter M et al. Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. 2009 Extremophiles pmid:19579003
Kornblatt JA et al. Structure-activity relationships of wheat flavone O-methyltransferase: a homodimer of convenience. 2008 FEBS J. pmid:18397325